Good development - Although press release calls out target patients at 100000, per Unicef this is much larger at 25X+, or 1L target size is only for second and third line treatments - which is being developed by Laurus, Dev and commercial expenses being funded by unitaid, gains should mostly flow to bottomline.
13 Likes